← Back to Screener
Medicus Pharma Ltd. Common Stock (MDCX)
Price$0.30
Favorite Metrics
Price vs S&P 500 (26W)-91.71%
Price vs S&P 500 (4W)-45.40%
Market Capitalization$11.89M
All Metrics
Book Value / Share (Quarterly)$0.16
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.21
Price vs S&P 500 (YTD)-82.90%
EPS (TTM)$-2.15
10-Day Avg Trading Volume6.06M
EPS Excl Extra (TTM)$-2.15
EPS (Annual)$-2.05
ROI (Annual)-355.87%
Cash / Share (Quarterly)$0.30
ROA (Last FY)-197.55%
EBITD / Share (TTM)$-2.21
ROE (5Y Avg)-242.43%
Cash Flow / Share (Annual)$-0.87
P/B Ratio5.54x
P/B Ratio (Quarterly)23.24x
Net Interest Coverage (TTM)-178.57x
ROA (TTM)-181.43%
EPS Incl Extra (Annual)$-2.05
Current Ratio (Annual)2.33x
Quick Ratio (Quarterly)1.19x
3-Month Avg Trading Volume3.38M
52-Week Price Return-91.63%
52-Week High$8.94
EPS Excl Extra (Annual)$-2.05
26-Week Price Return-87.72%
Quick Ratio (Annual)1.81x
13-Week Price Return-79.31%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.53x
Enterprise Value$7.909
Cash / Share (Annual)$0.35
3-Month Return Std Dev175.81%
ROE (Last FY)-355.87%
Net Interest Coverage (Annual)-29.00x
EPS Basic Excl Extra (Annual)$-2.05
P/FCF (TTM)3.91x
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-2.15
Receivables Turnover (Annual)0.00x
ROI (TTM)-285.41%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-121.46%
Year-to-Date Return-80.25%
5-Day Price Return-31.65%
EPS Normalized (Annual)$-2.05
ROA (5Y Avg)-4285.53%
Month-to-Date Return-34.18%
EBITD / Share (Annual)$-2.04
ROI (5Y Avg)-242.43%
EPS Basic Excl Extra (TTM)$-2.15
P/B Ratio (Annual)9.51x
Book Value / Share (Annual)$0.27
Price vs S&P 500 (13W)-80.00%
Beta2.26x
Revenue / Share (TTM)$0.00
ROE (TTM)-302.50%
52-Week Low$0.29
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.11
4.11
4.11
4.11
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
MDCXMedicus Pharma Ltd. Common Stock | — | — | — | — | $0.30 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
Medicus Pharma Ltd is a clinical-stage holding company that invests in and supports life sciences and biotechnology companies developing novel treatments. The company focuses on advancing therapies through FDA-regulated clinical development to address unmet patient needs and improve therapeutic outcomes.